As of 2026-03-30, 同仁牛黄清心丸's data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, below the industry average by 6.1 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 同仁牛黄清心丸's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
同仁牛黄清心丸's Mention Rate is 0.00%, lower than 0.6% of competitors
同仁牛黄清心丸's First Mention is 0.00%, lower than 0.9% of competitors
同仁牛黄清心丸's Preferred Rate is 0.00%, lower than 100.0% of competitors
同仁牛黄清心丸's Positive Rate is 0.00%, lower than 8.9% of competitors
同仁牛黄清心丸's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 司司美格鲁肽 | 29.73% | 0% | 0% | 18.92% | 5.41% | View Details |
| 白白云山 | 24.32% | 0% | 0% | 10.81% | 21.62% | View Details |
| 同同仁堂 | 24.32% | 0% | 0% | 10.81% | 18.92% | View Details |
| 恒恒瑞医药 | 16.22% | 2.7% | 0% | 16.22% | 0% | View Details |
| 云云南白药 | 13.51% | 0% | 0% | 13.51% | 0% | View Details |
| 百百济神州 | 13.51% | 0% | 0% | 13.51% | 0% | View Details |
| 同同仁牛黄清心丸 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
